ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,529,043, issued on Jan. 20, was assigned to EmendoBio Inc. (Wilmington, Del.).
"OMNI-103 CRISPR nuclease" was invented by Lior Izhar (Tel Aviv, Israel), Nadav Marbach Bar (Rehovot, Israel), Liat Rockah (Rishon LeZion, Israel), Nurit Meron (Ramat Gan, Israel), Ophir Adiv Tal (Rehovot, Israel), Ariel Gispan (Kfar Adumim, Israel), Idit Buch (Hod-Hasharon, Israel) and Nir Hecht (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a non-naturally occurring composition comprising a CRISPR nuclease comprising a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule ...